Tatva Chintan Pharma Chem Private Limited is one of the leading industries in the speciality chemicals sector. It was established in 1996 and its products can be classified into 4 segments, Structure directing agents (SDA), Phase transfer catalyst (PTC), Electrolyte salts and super capacitor batteries and Pharmaceutical & Agricultural intermediates & other speciality chemicals (PASC). They are the only and largest manufacturers of SDAs in India and they are the second largest globally. They are also the largest manufacturer of PTC in India.
They have a wide and diversified product portfolio and provides its services to automobile, agrochemicals, petroleum, paints, dyes & pigments, personal care and pharmaceutical industries. Some of its customers are Bayer AG, Laurus labs, Navin Fluorine International and Divi's laboratories and they are adding a lot of new customers every year. They export to 25 countries including the USA, UK, China, Germany, Japan and South Africa.
The company has 2 manufacturing facilities and they are strategically located near the ports so that it will be easy for them to serve the international markets. The company also has a good R & D facility which will help them to develop new products and increase their market share.
Peers
· Aarti Industries limited
· Navin Fluorine International limited
· Alkyl Amines Chemicals limited
· Vinati Organics limited
· Fine Organics Industries limited
TATVA CHINTAN PHARMA CHEM Financials
|
|
Total Assets |
Total Revenue |
Profit After Tax |
|
31-Mar-19 |
1,875.08 |
2,068.01 |
205.73 |
|
31-Mar-20 |
2,489.38 |
2,646.22 |
377.89 |
|
31-Mar-21 |
3,148.03 |
3,062.92 |
522.62 |
|
(in millions) |
|||
Structure directing agents contribute a major part of the company’s revenue. Electrolyte salts and super capacitor batteries contribute the least, this may improve in the future when the usage of electric vehicles increases. The other two segments also contribute a major part of the revenue. Revenue from international customers is around 70% whereas 30% is from domestic customers. The PE ratio is 41.62.
Objectives of the issue
· Funding capital expenditure requirements for expansion of our Dahej Manufacturing Facility.
· Funding capital expenditure requirements for upgradation at our R&D facility in Vadodara
· General corporate purposes.
Pros
· Largest manufacturers of SDA and PTC.
· Global presence.
· Good R&D, experienced management and financial performance.
Cons
· Major part of the company’s revenue is from exports.
TATVA CHINTAN PHARMA CHEM IPO details
|
Face value |
₹10 per equity share |
|
|
Issue Type |
Book built issue |
|
|
IPO Price Band |
₹1073 to ₹1083 per equity share |
|
|
Minimum Order Quantity |
13 Shares (1 Lot - ₹14,079) |
|
|
Maximum Order Quantity |
182 Shares (14 Lots - ₹1,97,106) |
|
|
Retail Portion |
35% |
|
|
Listing At |
BSE, NSE |
|
|
Issue Size |
₹ 500 Cr (approximate value) |
|
|
Fresh Issue |
₹ 225 Cr (approximate value) |
|
|
Offer For Sale |
₹ 275 Cr (approximate value) |
|
|
Grey market premium |
Approximately 60% of the issue price |
|
   
TATVA CHINTAN PHARMA CHEM IPO Important Dates
|
IPO Open Date |
July 16, 2021 |
|
IPO Close Date |
July 20, 2021 |
|
Basis of Allotment |
July 26, 2021 |
|
Initiation of Refunds |
July 27, 2021 |
|
Credit of Shares to Demat Account |
July 28, 2021 |
|
Listing Date |
July 29, 2021 |
TATVA CHINTAN PHARMA CHEM Promoters & Promoter holding
|
Promoters |
§ Ajaykumar Mansukhlal Patel § Chintan Nitinkumar Shah § Shekhar Rasiklal Somani |
|
|
Promoter Holding |
Pre-Issue |
100% |
|
Post Issue |
79.17% |
|
TATVA CHINTAN PHARMA CHEM Contact Information
Plot No. 502 / 17,
GIDC Estate,
Ankleshwar, Bharuch,
Gujarat – 393 002,
India
Email: mailto:cs@tatvachintan.com
Website: http://www.tatvachintan.com
Telephone: +91 75730 46951 / +91 75730 46952
TATVA CHINTAN PHARMA CHEM IPO Prospectus
· TATVA CHINTAN PHARMA CHEM IPO DRHP
· TATVA CHINTAN PHARMA CHEM IPO RHP
To open a Demat account and apply for the IPO click here
Check TATVA CHINTAN PHARMA CHEM IPO allotment status: https://www.linkintime.co.in/IPO/public-issues.html